Literature DB >> 30957234

Cytoplasmic cyclin D1 regulates glioblastoma dissemination.

Tània Cemeli1, Marta Guasch-Vallés1, Mireia Nàger2, Isidre Felip3, Serafí Cambray4, Maria Santacana5, Sònia Gatius5, Neus Pedraza1, Xavier Dolcet3, Francisco Ferrezuelo1, Alberto J Schuhmacher6, Judit Herreros2, Eloi Garí1.   

Abstract

Glioblastoma (GBM) is a highly invasive brain neoplasia with an elevated recurrence rate after surgical resection. The cyclin D1 (Ccnd1)/Cdk4-retinoblastoma 1 (RB1) axis is frequently altered in GBM, leading to overproliferation by RB1 deletion or by Ccnd1-Cdk4 overactivation. High levels of Ccnd1-Cdk4 also promote GBM cell invasion by mechanisms that are not so well understood. The purpose of this work is to elucidate the in vivo role of cytoplasmic Ccnd1-Cdk4 activity in the dissemination of GBM. We show that Ccnd1 activates the invasion of primary human GBM cells through cytoplasmic RB1-independent mechanisms. By using GBM mouse models, we observed that evaded GBM cells showed cytoplasmic Ccnd1 colocalizing with regulators of cell invasion such as RalA and paxillin. Our genetic data strongly suggest that, in GBM cells, the Ccnd1-Cdk4 complex is acting upstream of those regulators. Accordingly, expression of Ccnd1 induces focal adhesion kinase, RalA and Rac1 activities. Finally, in vivo experiments demonstrated increased GBM dissemination after expression of membrane-targeted Ccnd1. We conclude that Ccnd1-Cdk4 activity promotes GBM dissemination through cytoplasmic and RB1-independent mechanisms. Therefore, inhibition of Ccnd1-Cdk4 activity may be useful to hinder the dissemination of recurrent GBM.
© 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  cyclin D1; cytoplasm; glioblastoma; migration; tumor dissemination

Mesh:

Substances:

Year:  2019        PMID: 30957234     DOI: 10.1002/path.5277

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  MicroRNA 3928 Suppresses Glioblastoma through Downregulation of Several Oncogenes and Upregulation of p53.

Authors:  Elizabeth Q X Mulcahy; Ying Zhang; Rossymar R Colόn; Shelby R Cain; Myron K Gibert; Collin J Dube; Markus Hafner; Roger Abounader
Journal:  Int J Mol Sci       Date:  2022-04-01       Impact factor: 6.208

Review 2.  The double dealing of cyclin D1.

Authors:  Guergana Tchakarska; Brigitte Sola
Journal:  Cell Cycle       Date:  2019-12-29       Impact factor: 4.534

Review 3.  Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma-backbone or add-on in immune-oncology?

Authors:  Christin Riess; Nina Irmscher; Inken Salewski; Daniel Strüder; Carl-Friedrich Classen; Christina Große-Thie; Christian Junghanss; Claudia Maletzki
Journal:  Cancer Metastasis Rev       Date:  2020-11-08       Impact factor: 9.264

Review 4.  Cyclin D1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma.

Authors:  Francesca Ida Montalto; Francesca De Amicis
Journal:  Cells       Date:  2020-12-09       Impact factor: 6.600

5.  Antitumor Effects of Ral-GTPases Downregulation in Glioblastoma.

Authors:  Tània Cemeli; Marta Guasch-Vallés; Marina Ribes-Santolaria; Eva Ibars; Raúl Navaridas; Xavier Dolcet; Neus Pedraza; Neus Colomina; Jordi Torres-Rosell; Francisco Ferrezuelo; Judit Herreros; Eloi Garí
Journal:  Int J Mol Sci       Date:  2022-07-25       Impact factor: 6.208

6.  Antitumor Effects of 5-Aminolevulinic Acid on Human Malignant Glioblastoma Cells.

Authors:  Mohammad Jalili-Nik; Farzaneh Abbasinezhad-Moud; Sajad Sahab-Negah; Abolfazl Maghrouni; Mohammad Etezad Razavi; Maryam Khaleghi Ghadiri; Walter Stummer; Ali Gorji
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.